drugset
drugset / Trial / NCT03489941

A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle

NCT03489941 ↗

Phase 3 Completed 65 enrolled Bausch & Lomb Incorporated ORA, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

A Single-Center study to demonstrate the non-inferiority of EM-100 to Zaditor® in the treatment of ocular itching.

Timeline

Start
2018-04-07
Primary completion
2018-04-29
Completion
2018-04-29

Drugs

EvaluationDrugModalityDoseRoute
Subject EM-100 Unknown — Other
Subject Ketotifen Small molecule 0.035 % Other

Indications

conjunctivitis